Based on the online database, we analyzed the novel target genes and signaling pathways of NGR1 and breast cancer disease, and explored whether NGR1 could regulate ferroptosis in breast cancer and thus affect the progression of breast cancer cells, with the aim of providing new drug targets and therapeutic options for breast cancer patients. The gene discussed is RTN4R; the disease is breast carcinoma.